Replies to post #102 on Aptose Biosciences Inc (APTOF)

[Bangtime]

Strictly a back test of the highs previously this year. Now should move higher with a near term 5 target based on technicals only. Add the fundamentals, who knows how high. Waiting in the wings nearby 253 FDA hold lifted and 806 IND.

[TheFinalCD]

“We are eager to return APTO-253 back into the clinic,” said William G. Rice, Ph.D., Chairman, President and Chief Executive Officer. “Our understanding of this molecule has evolved dramatically, and we are excited to deliver a MYC gene expression inhibitor to patients with debilitating hematologic malignancies.”